Watson Receives FDA Approval For Generic DuoNeb

Watson Pharmaceuticals has received final approval from FDA on its ANDA for Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.

This entry was posted on Friday, January 4th, 2008 at 10:10 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.